Global Interventional Oncology Microspheres Market Growth 2026-2032

Product Code: 2023984

Industry: Medical Devices & Consumables

Published: Aug 06,2026

Pages: 161

Delivery Time: 2-3 business days

Global Interventional Oncology Microspheres Market Growth 2026-2032

Product Code: 2023984

Industry: Medical Devices & Consumables

Published: Aug 06,2026

Pages: 161

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Interventional Oncology Microspheres market size is predicted to grow from US$ 633 million in 2025 to US$ 951 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

In 2025, global interventional oncology microspheres average price is 1260 usd/unit.

Interventional Oncology Microspheres are sterile, size-calibrated spherical particles delivered through angiographic catheters or microcatheters into arteries supplying solid tumors. The products are designed to achieve one or more locoregional therapeutic functions: mechanical occlusion of tumor-feeding vessels, controlled local delivery of chemotherapeutic agents, or deposition of therapeutic radioisotopes within tumor microvasculature. The market principally covers bland embolization microspheres, drug-loadable or drug-eluting microspheres, resorbable or biodegradable microspheres, radiopaque or otherwise imageable microspheres, and radioactive microspheres based on isotopes such as yttrium-90. Product structures include cross-linked hydrogel, polyvinyl alcohol, polyethylene glycol, acrylic copolymer, degradable starch, biodegradable polymer, resin and glass microspheres. Interventional Oncology Microspheres are primarily used in transarterial embolization, transarterial chemoembolization and transarterial radioembolization for hepatocellular carcinoma, liver metastases and other hypervascular tumors, with product selection determined by tumor vascularity, target-vessel anatomy, treatment objective and approved indication.

United States market for Interventional Oncology Microspheres is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Interventional Oncology Microspheres is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Interventional Oncology Microspheres is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Interventional Oncology Microspheres players cover Boston Scientific Corporation, Merit Medical Systems, Inc., Terumo Corporation, Sirtex Medical Pty Ltd., Varian Medical Systems, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Interventional Oncology Microspheres Industry Forecast” looks at past sales and reviews total world Interventional Oncology Microspheres sales in 2025, providing a comprehensive analysis by region and market sector of projected Interventional Oncology Microspheres sales for 2026 through 2032. With Interventional Oncology Microspheres sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Oncology Microspheres industry.

This Insight Report provides a comprehensive analysis of the global Interventional Oncology Microspheres landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interventional Oncology Microspheres portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Interventional Oncology Microspheres market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Oncology Microspheres and breaks down the forecast by Function, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Oncology Microspheres.

This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Oncology Microspheres market by product type, application, key manufacturers and key regions and countries.

Market Segmentation
Segmentation by Function:
Bland Embolization Microspheres
Drug-Loadable and Drug-Eluting Microspheres
Radioembolization Microspheres

Segmentation by Resorbable:
Nonresorbable Microspheres
Resorbable Microspheres
Biodegradable Microspheres

Segmentation by Application:
Hepatocellular Carcinoma
Colorectal Cancer Liver Metastases
Neuroendocrine Tumor Liver Metastases
Intrahepatic Cholangiocarcinoma
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Boston Scientific Corporation
Merit Medical Systems, Inc.
Terumo Corporation
Sirtex Medical Pty Ltd.
Varian Medical Systems, Inc.
ABK Biomedical Inc.
IMBiotechnologies Ltd.
Magle Group AB
Serumwerk Bernburg AG
Teleflex Incorporated
Suzhou Mednova Yi Medical Technology Co., Ltd.
Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.
Shanghai H&H Healthcare Technology Company Ltd.
Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd.
Shanghai Weimu Medical Technology Co., Ltd.
Shanghai Yisimiao Medical Devices Co., Ltd.
Hainan Baimaike Medical Technology Co., Ltd.
Hunan APT Medical Inc.
Shanghai Tuomai Medical Technology Co., Ltd.
Huanxin Medical Technology (Suzhou) Co., Ltd.
Digray Medical Technology (Suzhou) Co., Ltd.
Shanghai Fangrun Interventional Medical Devices Co., Ltd.
Hangzhou Yangshun Medical Technology Co., Ltd.
Suzhou Haowei Biomedical Technology Co., Ltd.

Key Questions Addressed in this Report
What is the 10-year outlook for the global Interventional Oncology Microspheres market?
What factors are driving Interventional Oncology Microspheres market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Interventional Oncology Microspheres market opportunities vary by end market size?
How does Interventional Oncology Microspheres break out by Function, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Interventional Oncology Microspheres Annual Sales 2021-2032
        2.1.2 World Current & Future Analysis for Interventional Oncology Microspheres by Geographic Region, 2021, 2025 & 2032
        2.1.3 World Current & Future Analysis for Interventional Oncology Microspheres by Country/Region, 2021, 2025 & 2032
    2.2 Interventional Oncology Microspheres Segment by Function
        2.2.1 Bland Embolization Microspheres
        2.2.2 Drug-Loadable and Drug-Eluting Microspheres
        2.2.3 Radioembolization Microspheres
        2.2.4 Interventional Oncology Microspheres Sales by Function
            2.2.4.1 Global Interventional Oncology Microspheres Sales Market Share by Function (2021-2026)
            2.2.4.2 Global Interventional Oncology Microspheres Revenue and Market Share by Function (2021-2026)
            2.2.4.3 Global Interventional Oncology Microspheres Sale Price by Function (2021-2026)
    2.3 Interventional Oncology Microspheres Segment by Resorbable
        2.3.1 Nonresorbable Microspheres
        2.3.2 Resorbable Microspheres
        2.3.3 Biodegradable Microspheres
        2.3.4 Interventional Oncology Microspheres Sales by Resorbable
            2.3.4.1 Global Interventional Oncology Microspheres Sales Market Share by Resorbable (2021-2026)
            2.3.4.2 Global Interventional Oncology Microspheres Revenue and Market Share by Resorbable (2021-2026)
            2.3.4.3 Global Interventional Oncology Microspheres Sale Price by Resorbable (2021-2026)
    2.4 Interventional Oncology Microspheres Segment by Application
        2.4.1 Hepatocellular Carcinoma
        2.4.2 Colorectal Cancer Liver Metastases
        2.4.3 Neuroendocrine Tumor Liver Metastases
        2.4.4 Intrahepatic Cholangiocarcinoma
        2.4.5 Others
        2.4.6 Interventional Oncology Microspheres Sales by Application
            2.4.6.1 Global Interventional Oncology Microspheres Sale Market Share by Application (2021-2026)
            2.4.6.2 Global Interventional Oncology Microspheres Revenue and Market Share by Application (2021-2026)
            2.4.6.3 Global Interventional Oncology Microspheres Sale Price by Application (2021-2026)

3 Global by Company
    3.1 Global Interventional Oncology Microspheres Breakdown Data by Company
        3.1.1 Global Interventional Oncology Microspheres Annual Sales by Company (2021-2026)
        3.1.2 Global Interventional Oncology Microspheres Sales Market Share by Company (2021-2026)
    3.2 Global Interventional Oncology Microspheres Annual Revenue by Company (2021-2026)
        3.2.1 Global Interventional Oncology Microspheres Revenue by Company (2021-2026)
        3.2.2 Global Interventional Oncology Microspheres Revenue Market Share by Company (2021-2026)
    3.3 Global Interventional Oncology Microspheres Sale Price by Company
    3.4 Key Manufacturers Interventional Oncology Microspheres Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Interventional Oncology Microspheres Product Location Distribution
        3.4.2 Players Interventional Oncology Microspheres Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Interventional Oncology Microspheres by Geographic Region
    4.1 World Historic Interventional Oncology Microspheres Market Size by Geographic Region (2021-2026)
        4.1.1 Global Interventional Oncology Microspheres Annual Sales by Geographic Region (2021-2026)
        4.1.2 Global Interventional Oncology Microspheres Annual Revenue by Geographic Region (2021-2026)
    4.2 World Historic Interventional Oncology Microspheres Market Size by Country/Region (2021-2026)
        4.2.1 Global Interventional Oncology Microspheres Annual Sales by Country/Region (2021-2026)
        4.2.2 Global Interventional Oncology Microspheres Annual Revenue by Country/Region (2021-2026)
    4.3 Americas Interventional Oncology Microspheres Sales Growth
    4.4 APAC Interventional Oncology Microspheres Sales Growth
    4.5 Europe Interventional Oncology Microspheres Sales Growth
    4.6 Middle East & Africa Interventional Oncology Microspheres Sales Growth

5 Americas
    5.1 Americas Interventional Oncology Microspheres Sales by Country
        5.1.1 Americas Interventional Oncology Microspheres Sales by Country (2021-2026)
        5.1.2 Americas Interventional Oncology Microspheres Revenue by Country (2021-2026)
    5.2 Americas Interventional Oncology Microspheres Sales by Function (2021-2026)
    5.3 Americas Interventional Oncology Microspheres Sales by Application (2021-2026)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Interventional Oncology Microspheres Sales by Region
        6.1.1 APAC Interventional Oncology Microspheres Sales by Region (2021-2026)
        6.1.2 APAC Interventional Oncology Microspheres Revenue by Region (2021-2026)
    6.2 APAC Interventional Oncology Microspheres Sales by Function (2021-2026)
    6.3 APAC Interventional Oncology Microspheres Sales by Application (2021-2026)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Interventional Oncology Microspheres by Country
        7.1.1 Europe Interventional Oncology Microspheres Sales by Country (2021-2026)
        7.1.2 Europe Interventional Oncology Microspheres Revenue by Country (2021-2026)
    7.2 Europe Interventional Oncology Microspheres Sales by Function (2021-2026)
    7.3 Europe Interventional Oncology Microspheres Sales by Application (2021-2026)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Interventional Oncology Microspheres by Country
        8.1.1 Middle East & Africa Interventional Oncology Microspheres Sales by Country (2021-2026)
        8.1.2 Middle East & Africa Interventional Oncology Microspheres Revenue by Country (2021-2026)
    8.2 Middle East & Africa Interventional Oncology Microspheres Sales by Function (2021-2026)
    8.3 Middle East & Africa Interventional Oncology Microspheres Sales by Application (2021-2026)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Interventional Oncology Microspheres
    10.3 Manufacturing Process Analysis of Interventional Oncology Microspheres
    10.4 Industry Chain Structure of Interventional Oncology Microspheres

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Interventional Oncology Microspheres Distributors
    11.3 Interventional Oncology Microspheres Customer

12 World Forecast Review for Interventional Oncology Microspheres by Geographic Region
    12.1 Global Interventional Oncology Microspheres Market Size Forecast by Region
        12.1.1 Global Interventional Oncology Microspheres Forecast by Region (2027-2032)
        12.1.2 Global Interventional Oncology Microspheres Annual Revenue Forecast by Region (2027-2032)
    12.2 Americas Forecast by Country (2027-2032)
    12.3 APAC Forecast by Region (2027-2032)
    12.4 Europe Forecast by Country (2027-2032)
    12.5 Middle East & Africa Forecast by Country (2027-2032)
    12.6 Global Interventional Oncology Microspheres Forecast by Function (2027-2032)
    12.7 Global Interventional Oncology Microspheres Forecast by Application (2027-2032)

13 Key Players Analysis
13.1 Boston Scientific Corporation
13.1.1 Boston Scientific Corporation Company Information
13.1.2 Boston Scientific Corporation Interventional Oncology Microspheres Product Portfolios and Specifications
13.1.3 Boston Scientific Corporation Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boston Scientific Corporation Main Business Overview
13.1.5 Boston Scientific Corporation Latest Developments
13.2 Merit Medical Systems, Inc.
13.2.1 Merit Medical Systems, Inc. Company Information
13.2.2 Merit Medical Systems, Inc. Interventional Oncology Microspheres Product Portfolios and Specifications
13.2.3 Merit Medical Systems, Inc. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merit Medical Systems, Inc. Main Business Overview
13.2.5 Merit Medical Systems, Inc. Latest Developments
13.3 Terumo Corporation
13.3.1 Terumo Corporation Company Information
13.3.2 Terumo Corporation Interventional Oncology Microspheres Product Portfolios and Specifications
13.3.3 Terumo Corporation Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Terumo Corporation Main Business Overview
13.3.5 Terumo Corporation Latest Developments
13.4 Sirtex Medical Pty Ltd.
13.4.1 Sirtex Medical Pty Ltd. Company Information
13.4.2 Sirtex Medical Pty Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.4.3 Sirtex Medical Pty Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sirtex Medical Pty Ltd. Main Business Overview
13.4.5 Sirtex Medical Pty Ltd. Latest Developments
13.5 Varian Medical Systems, Inc.
13.5.1 Varian Medical Systems, Inc. Company Information
13.5.2 Varian Medical Systems, Inc. Interventional Oncology Microspheres Product Portfolios and Specifications
13.5.3 Varian Medical Systems, Inc. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Varian Medical Systems, Inc. Main Business Overview
13.5.5 Varian Medical Systems, Inc. Latest Developments
13.6 ABK Biomedical Inc.
13.6.1 ABK Biomedical Inc. Company Information
13.6.2 ABK Biomedical Inc. Interventional Oncology Microspheres Product Portfolios and Specifications
13.6.3 ABK Biomedical Inc. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 ABK Biomedical Inc. Main Business Overview
13.6.5 ABK Biomedical Inc. Latest Developments
13.7 IMBiotechnologies Ltd.
13.7.1 IMBiotechnologies Ltd. Company Information
13.7.2 IMBiotechnologies Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.7.3 IMBiotechnologies Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 IMBiotechnologies Ltd. Main Business Overview
13.7.5 IMBiotechnologies Ltd. Latest Developments
13.8 Magle Group AB
13.8.1 Magle Group AB Company Information
13.8.2 Magle Group AB Interventional Oncology Microspheres Product Portfolios and Specifications
13.8.3 Magle Group AB Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Magle Group AB Main Business Overview
13.8.5 Magle Group AB Latest Developments
13.9 Serumwerk Bernburg AG
13.9.1 Serumwerk Bernburg AG Company Information
13.9.2 Serumwerk Bernburg AG Interventional Oncology Microspheres Product Portfolios and Specifications
13.9.3 Serumwerk Bernburg AG Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Serumwerk Bernburg AG Main Business Overview
13.9.5 Serumwerk Bernburg AG Latest Developments
13.10 Teleflex Incorporated
13.10.1 Teleflex Incorporated Company Information
13.10.2 Teleflex Incorporated Interventional Oncology Microspheres Product Portfolios and Specifications
13.10.3 Teleflex Incorporated Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Teleflex Incorporated Main Business Overview
13.10.5 Teleflex Incorporated Latest Developments
13.11 Suzhou Mednova Yi Medical Technology Co., Ltd.
13.11.1 Suzhou Mednova Yi Medical Technology Co., Ltd. Company Information
13.11.2 Suzhou Mednova Yi Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.11.3 Suzhou Mednova Yi Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Suzhou Mednova Yi Medical Technology Co., Ltd. Main Business Overview
13.11.5 Suzhou Mednova Yi Medical Technology Co., Ltd. Latest Developments
13.12 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.
13.12.1 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Company Information
13.12.2 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.12.3 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Main Business Overview
13.12.5 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Latest Developments
13.13 Shanghai H&H Healthcare Technology Company Ltd.
13.13.1 Shanghai H&H Healthcare Technology Company Ltd. Company Information
13.13.2 Shanghai H&H Healthcare Technology Company Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.13.3 Shanghai H&H Healthcare Technology Company Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai H&H Healthcare Technology Company Ltd. Main Business Overview
13.13.5 Shanghai H&H Healthcare Technology Company Ltd. Latest Developments
13.14 Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd.
13.14.1 Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. Company Information
13.14.2 Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.14.3 Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. Main Business Overview
13.14.5 Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. Latest Developments
13.15 Shanghai Weimu Medical Technology Co., Ltd.
13.15.1 Shanghai Weimu Medical Technology Co., Ltd. Company Information
13.15.2 Shanghai Weimu Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.15.3 Shanghai Weimu Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Shanghai Weimu Medical Technology Co., Ltd. Main Business Overview
13.15.5 Shanghai Weimu Medical Technology Co., Ltd. Latest Developments
13.16 Shanghai Yisimiao Medical Devices Co., Ltd.
13.16.1 Shanghai Yisimiao Medical Devices Co., Ltd. Company Information
13.16.2 Shanghai Yisimiao Medical Devices Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.16.3 Shanghai Yisimiao Medical Devices Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Shanghai Yisimiao Medical Devices Co., Ltd. Main Business Overview
13.16.5 Shanghai Yisimiao Medical Devices Co., Ltd. Latest Developments
13.17 Hainan Baimaike Medical Technology Co., Ltd.
13.17.1 Hainan Baimaike Medical Technology Co., Ltd. Company Information
13.17.2 Hainan Baimaike Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.17.3 Hainan Baimaike Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Hainan Baimaike Medical Technology Co., Ltd. Main Business Overview
13.17.5 Hainan Baimaike Medical Technology Co., Ltd. Latest Developments
13.18 Hunan APT Medical Inc.
13.18.1 Hunan APT Medical Inc. Company Information
13.18.2 Hunan APT Medical Inc. Interventional Oncology Microspheres Product Portfolios and Specifications
13.18.3 Hunan APT Medical Inc. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Hunan APT Medical Inc. Main Business Overview
13.18.5 Hunan APT Medical Inc. Latest Developments
13.19 Shanghai Tuomai Medical Technology Co., Ltd.
13.19.1 Shanghai Tuomai Medical Technology Co., Ltd. Company Information
13.19.2 Shanghai Tuomai Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.19.3 Shanghai Tuomai Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Shanghai Tuomai Medical Technology Co., Ltd. Main Business Overview
13.19.5 Shanghai Tuomai Medical Technology Co., Ltd. Latest Developments
13.20 Huanxin Medical Technology (Suzhou) Co., Ltd.
13.20.1 Huanxin Medical Technology (Suzhou) Co., Ltd. Company Information
13.20.2 Huanxin Medical Technology (Suzhou) Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.20.3 Huanxin Medical Technology (Suzhou) Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Huanxin Medical Technology (Suzhou) Co., Ltd. Main Business Overview
13.20.5 Huanxin Medical Technology (Suzhou) Co., Ltd. Latest Developments
13.21 Digray Medical Technology (Suzhou) Co., Ltd.
13.21.1 Digray Medical Technology (Suzhou) Co., Ltd. Company Information
13.21.2 Digray Medical Technology (Suzhou) Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.21.3 Digray Medical Technology (Suzhou) Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Digray Medical Technology (Suzhou) Co., Ltd. Main Business Overview
13.21.5 Digray Medical Technology (Suzhou) Co., Ltd. Latest Developments
13.22 Shanghai Fangrun Interventional Medical Devices Co., Ltd.
13.22.1 Shanghai Fangrun Interventional Medical Devices Co., Ltd. Company Information
13.22.2 Shanghai Fangrun Interventional Medical Devices Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.22.3 Shanghai Fangrun Interventional Medical Devices Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Shanghai Fangrun Interventional Medical Devices Co., Ltd. Main Business Overview
13.22.5 Shanghai Fangrun Interventional Medical Devices Co., Ltd. Latest Developments
13.23 Hangzhou Yangshun Medical Technology Co., Ltd.
13.23.1 Hangzhou Yangshun Medical Technology Co., Ltd. Company Information
13.23.2 Hangzhou Yangshun Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.23.3 Hangzhou Yangshun Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Hangzhou Yangshun Medical Technology Co., Ltd. Main Business Overview
13.23.5 Hangzhou Yangshun Medical Technology Co., Ltd. Latest Developments
13.24 Suzhou Haowei Biomedical Technology Co., Ltd.
13.24.1 Suzhou Haowei Biomedical Technology Co., Ltd. Company Information
13.24.2 Suzhou Haowei Biomedical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
13.24.3 Suzhou Haowei Biomedical Technology Co., Ltd. Interventional Oncology Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Suzhou Haowei Biomedical Technology Co., Ltd. Main Business Overview
13.24.5 Suzhou Haowei Biomedical Technology Co., Ltd. Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Interventional Oncology Microspheres Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Table 2. Interventional Oncology Microspheres Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
 Table 3. Major Players of Bland Embolization Microspheres
 Table 4. Major Players of Drug-Loadable and Drug-Eluting Microspheres
 Table 5. Major Players of Radioembolization Microspheres
 Table 6. Global Interventional Oncology Microspheres Sales by Function (2021-2026) & (K Units)
 Table 7. Global Interventional Oncology Microspheres Sales Market Share by Function (2021-2026)
 Table 8. Global Interventional Oncology Microspheres Revenue by Function (2021-2026) & ($ million)
 Table 9. Global Interventional Oncology Microspheres Revenue Market Share by Function (2021-2026)
 Table 10. Global Interventional Oncology Microspheres Sale Price by Function (2021-2026) & (US$/Unit)
 Table 11. Major Players of Nonresorbable Microspheres
 Table 12. Major Players of Resorbable Microspheres
 Table 13. Major Players of Biodegradable Microspheres
 Table 14. Global Interventional Oncology Microspheres Sales by Resorbable (2021-2026) & (K Units)
 Table 15. Global Interventional Oncology Microspheres Sales Market Share by Resorbable (2021-2026)
 Table 16. Global Interventional Oncology Microspheres Revenue by Resorbable (2021-2026) & ($ million)
 Table 17. Global Interventional Oncology Microspheres Revenue Market Share by Resorbable (2021-2026)
 Table 18. Global Interventional Oncology Microspheres Sale Price by Resorbable (2021-2026) & (US$/Unit)
 Table 19. Global Interventional Oncology Microspheres Sale by Application (2021-2026) & (K Units)
 Table 20. Global Interventional Oncology Microspheres Sale Market Share by Application (2021-2026)
 Table 21. Global Interventional Oncology Microspheres Revenue by Application (2021-2026) & ($ million)
 Table 22. Global Interventional Oncology Microspheres Revenue Market Share by Application (2021-2026)
 Table 23. Global Interventional Oncology Microspheres Sale Price by Application (2021-2026) & (US$/Unit)
 Table 24. Global Interventional Oncology Microspheres Sales by Company (2021-2026) & (K Units)
 Table 25. Global Interventional Oncology Microspheres Sales Market Share by Company (2021-2026)
 Table 26. Global Interventional Oncology Microspheres Revenue by Company (2021-2026) & ($ millions)
 Table 27. Global Interventional Oncology Microspheres Revenue Market Share by Company (2021-2026)
 Table 28. Global Interventional Oncology Microspheres Sale Price by Company (2021-2026) & (US$/Unit)
 Table 29. Key Manufacturers Interventional Oncology Microspheres Producing Area Distribution and Sales Area
 Table 30. Players Interventional Oncology Microspheres Products Offered
 Table 31. Interventional Oncology Microspheres Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
 Table 32. New Products and Potential Entrants
 Table 33. Market M&A Activity & Strategy
 Table 34. Global Interventional Oncology Microspheres Sales by Geographic Region (2021-2026) & (K Units)
 Table 35. Global Interventional Oncology Microspheres Sales Market Share Geographic Region (2021-2026)
 Table 36. Global Interventional Oncology Microspheres Revenue by Geographic Region (2021-2026) & ($ millions)
 Table 37. Global Interventional Oncology Microspheres Revenue Market Share by Geographic Region (2021-2026)
 Table 38. Global Interventional Oncology Microspheres Sales by Country/Region (2021-2026) & (K Units)
 Table 39. Global Interventional Oncology Microspheres Sales Market Share by Country/Region (2021-2026)
 Table 40. Global Interventional Oncology Microspheres Revenue by Country/Region (2021-2026) & ($ millions)
 Table 41. Global Interventional Oncology Microspheres Revenue Market Share by Country/Region (2021-2026)
 Table 42. Americas Interventional Oncology Microspheres Sales by Country (2021-2026) & (K Units)
 Table 43. Americas Interventional Oncology Microspheres Sales Market Share by Country (2021-2026)
 Table 44. Americas Interventional Oncology Microspheres Revenue by Country (2021-2026) & ($ millions)
 Table 45. Americas Interventional Oncology Microspheres Sales by Function (2021-2026) & (K Units)
 Table 46. Americas Interventional Oncology Microspheres Sales by Application (2021-2026) & (K Units)
 Table 47. APAC Interventional Oncology Microspheres Sales by Region (2021-2026) & (K Units)
 Table 48. APAC Interventional Oncology Microspheres Sales Market Share by Region (2021-2026)
 Table 49. APAC Interventional Oncology Microspheres Revenue by Region (2021-2026) & ($ millions)
 Table 50. APAC Interventional Oncology Microspheres Sales by Function (2021-2026) & (K Units)
 Table 51. APAC Interventional Oncology Microspheres Sales by Application (2021-2026) & (K Units)
 Table 52. Europe Interventional Oncology Microspheres Sales by Country (2021-2026) & (K Units)
 Table 53. Europe Interventional Oncology Microspheres Revenue by Country (2021-2026) & ($ millions)
 Table 54. Europe Interventional Oncology Microspheres Sales by Function (2021-2026) & (K Units)
 Table 55. Europe Interventional Oncology Microspheres Sales by Application (2021-2026) & (K Units)
 Table 56. Middle East & Africa Interventional Oncology Microspheres Sales by Country (2021-2026) & (K Units)
 Table 57. Middle East & Africa Interventional Oncology Microspheres Revenue Market Share by Country (2021-2026)
 Table 58. Middle East & Africa Interventional Oncology Microspheres Sales by Function (2021-2026) & (K Units)
 Table 59. Middle East & Africa Interventional Oncology Microspheres Sales by Application (2021-2026) & (K Units)
 Table 60. Key Market Drivers & Growth Opportunities of Interventional Oncology Microspheres
 Table 61. Key Market Challenges & Risks of Interventional Oncology Microspheres
 Table 62. Key Industry Trends of Interventional Oncology Microspheres
 Table 63. Interventional Oncology Microspheres Raw Material
 Table 64. Key Suppliers of Raw Materials
 Table 65. Interventional Oncology Microspheres Distributors List
 Table 66. Interventional Oncology Microspheres Customer List
 Table 67. Global Interventional Oncology Microspheres Sales Forecast by Region (2027-2032) & (K Units)
 Table 68. Global Interventional Oncology Microspheres Revenue Forecast by Region (2027-2032) & ($ millions)
 Table 69. Americas Interventional Oncology Microspheres Sales Forecast by Country (2027-2032) & (K Units)
 Table 70. Americas Interventional Oncology Microspheres Annual Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 71. APAC Interventional Oncology Microspheres Sales Forecast by Region (2027-2032) & (K Units)
 Table 72. APAC Interventional Oncology Microspheres Annual Revenue Forecast by Region (2027-2032) & ($ millions)
 Table 73. Europe Interventional Oncology Microspheres Sales Forecast by Country (2027-2032) & (K Units)
 Table 74. Europe Interventional Oncology Microspheres Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 75. Middle East & Africa Interventional Oncology Microspheres Sales Forecast by Country (2027-2032) & (K Units)
 Table 76. Middle East & Africa Interventional Oncology Microspheres Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 77. Global Interventional Oncology Microspheres Sales Forecast by Function (2027-2032) & (K Units)
 Table 78. Global Interventional Oncology Microspheres Revenue Forecast by Function (2027-2032) & ($ millions)
 Table 79. Global Interventional Oncology Microspheres Sales Forecast by Application (2027-2032) & (K Units)
 Table 80. Global Interventional Oncology Microspheres Revenue Forecast by Application (2027-2032) & ($ millions)
 Table 81. Boston Scientific Corporation Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 82. Boston Scientific Corporation Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 83. Boston Scientific Corporation Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 84. Boston Scientific Corporation Main Business
 Table 85. Boston Scientific Corporation Latest Developments
 Table 86. Merit Medical Systems, Inc. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 87. Merit Medical Systems, Inc. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 88. Merit Medical Systems, Inc. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 89. Merit Medical Systems, Inc. Main Business
 Table 90. Merit Medical Systems, Inc. Latest Developments
 Table 91. Terumo Corporation Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 92. Terumo Corporation Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 93. Terumo Corporation Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 94. Terumo Corporation Main Business
 Table 95. Terumo Corporation Latest Developments
 Table 96. Sirtex Medical Pty Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 97. Sirtex Medical Pty Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 98. Sirtex Medical Pty Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 99. Sirtex Medical Pty Ltd. Main Business
 Table 100. Sirtex Medical Pty Ltd. Latest Developments
 Table 101. Varian Medical Systems, Inc. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 102. Varian Medical Systems, Inc. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 103. Varian Medical Systems, Inc. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 104. Varian Medical Systems, Inc. Main Business
 Table 105. Varian Medical Systems, Inc. Latest Developments
 Table 106. ABK Biomedical Inc. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 107. ABK Biomedical Inc. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 108. ABK Biomedical Inc. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 109. ABK Biomedical Inc. Main Business
 Table 110. ABK Biomedical Inc. Latest Developments
 Table 111. IMBiotechnologies Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 112. IMBiotechnologies Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 113. IMBiotechnologies Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 114. IMBiotechnologies Ltd. Main Business
 Table 115. IMBiotechnologies Ltd. Latest Developments
 Table 116. Magle Group AB Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 117. Magle Group AB Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 118. Magle Group AB Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 119. Magle Group AB Main Business
 Table 120. Magle Group AB Latest Developments
 Table 121. Serumwerk Bernburg AG Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 122. Serumwerk Bernburg AG Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 123. Serumwerk Bernburg AG Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 124. Serumwerk Bernburg AG Main Business
 Table 125. Serumwerk Bernburg AG Latest Developments
 Table 126. Teleflex Incorporated Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 127. Teleflex Incorporated Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 128. Teleflex Incorporated Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 129. Teleflex Incorporated Main Business
 Table 130. Teleflex Incorporated Latest Developments
 Table 131. Suzhou Mednova Yi Medical Technology Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 132. Suzhou Mednova Yi Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 133. Suzhou Mednova Yi Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 134. Suzhou Mednova Yi Medical Technology Co., Ltd. Main Business
 Table 135. Suzhou Mednova Yi Medical Technology Co., Ltd. Latest Developments
 Table 136. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 137. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 138. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 139. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Main Business
 Table 140. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Latest Developments
 Table 141. Shanghai H&H Healthcare Technology Company Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 142. Shanghai H&H Healthcare Technology Company Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 143. Shanghai H&H Healthcare Technology Company Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 144. Shanghai H&H Healthcare Technology Company Ltd. Main Business
 Table 145. Shanghai H&H Healthcare Technology Company Ltd. Latest Developments
 Table 146. Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 147. Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 148. Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 149. Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. Main Business
 Table 150. Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. Latest Developments
 Table 151. Shanghai Weimu Medical Technology Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 152. Shanghai Weimu Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 153. Shanghai Weimu Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 154. Shanghai Weimu Medical Technology Co., Ltd. Main Business
 Table 155. Shanghai Weimu Medical Technology Co., Ltd. Latest Developments
 Table 156. Shanghai Yisimiao Medical Devices Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 157. Shanghai Yisimiao Medical Devices Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 158. Shanghai Yisimiao Medical Devices Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 159. Shanghai Yisimiao Medical Devices Co., Ltd. Main Business
 Table 160. Shanghai Yisimiao Medical Devices Co., Ltd. Latest Developments
 Table 161. Hainan Baimaike Medical Technology Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 162. Hainan Baimaike Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 163. Hainan Baimaike Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 164. Hainan Baimaike Medical Technology Co., Ltd. Main Business
 Table 165. Hainan Baimaike Medical Technology Co., Ltd. Latest Developments
 Table 166. Hunan APT Medical Inc. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 167. Hunan APT Medical Inc. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 168. Hunan APT Medical Inc. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 169. Hunan APT Medical Inc. Main Business
 Table 170. Hunan APT Medical Inc. Latest Developments
 Table 171. Shanghai Tuomai Medical Technology Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 172. Shanghai Tuomai Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 173. Shanghai Tuomai Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 174. Shanghai Tuomai Medical Technology Co., Ltd. Main Business
 Table 175. Shanghai Tuomai Medical Technology Co., Ltd. Latest Developments
 Table 176. Huanxin Medical Technology (Suzhou) Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 177. Huanxin Medical Technology (Suzhou) Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 178. Huanxin Medical Technology (Suzhou) Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 179. Huanxin Medical Technology (Suzhou) Co., Ltd. Main Business
 Table 180. Huanxin Medical Technology (Suzhou) Co., Ltd. Latest Developments
 Table 181. Digray Medical Technology (Suzhou) Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 182. Digray Medical Technology (Suzhou) Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 183. Digray Medical Technology (Suzhou) Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 184. Digray Medical Technology (Suzhou) Co., Ltd. Main Business
 Table 185. Digray Medical Technology (Suzhou) Co., Ltd. Latest Developments
 Table 186. Shanghai Fangrun Interventional Medical Devices Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 187. Shanghai Fangrun Interventional Medical Devices Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 188. Shanghai Fangrun Interventional Medical Devices Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 189. Shanghai Fangrun Interventional Medical Devices Co., Ltd. Main Business
 Table 190. Shanghai Fangrun Interventional Medical Devices Co., Ltd. Latest Developments
 Table 191. Hangzhou Yangshun Medical Technology Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 192. Hangzhou Yangshun Medical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 193. Hangzhou Yangshun Medical Technology Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 194. Hangzhou Yangshun Medical Technology Co., Ltd. Main Business
 Table 195. Hangzhou Yangshun Medical Technology Co., Ltd. Latest Developments
 Table 196. Suzhou Haowei Biomedical Technology Co., Ltd. Basic Information, Interventional Oncology Microspheres Manufacturing Base, Sales Area and Its Competitors
 Table 197. Suzhou Haowei Biomedical Technology Co., Ltd. Interventional Oncology Microspheres Product Portfolios and Specifications
 Table 198. Suzhou Haowei Biomedical Technology Co., Ltd. Interventional Oncology Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 199. Suzhou Haowei Biomedical Technology Co., Ltd. Main Business
 Table 200. Suzhou Haowei Biomedical Technology Co., Ltd. Latest Developments


List of Figures
 Figure 1. Picture of Interventional Oncology Microspheres
 Figure 2. Interventional Oncology Microspheres Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Interventional Oncology Microspheres Sales Growth Rate 2021-2032 (K Units)
 Figure 7. Global Interventional Oncology Microspheres Revenue Growth Rate 2021-2032 ($ millions)
 Figure 8. Interventional Oncology Microspheres Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Figure 9. Interventional Oncology Microspheres Sales Market Share by Country/Region (2025)
 Figure 10. Interventional Oncology Microspheres Sales Market Share by Country/Region (2021, 2025 & 2032)
 Figure 11. Product Picture of Bland Embolization Microspheres
 Figure 12. Product Picture of Drug-Loadable and Drug-Eluting Microspheres
 Figure 13. Product Picture of Radioembolization Microspheres
 Figure 14. Global Interventional Oncology Microspheres Sales Market Share by Function in 2026
 Figure 15. Global Interventional Oncology Microspheres Revenue Market Share by Function (2021-2026)
 Figure 16. Product Picture of Nonresorbable Microspheres
 Figure 17. Product Picture of Resorbable Microspheres
 Figure 18. Product Picture of Biodegradable Microspheres
 Figure 19. Global Interventional Oncology Microspheres Sales Market Share by Resorbable in 2026
 Figure 20. Global Interventional Oncology Microspheres Revenue Market Share by Resorbable (2021-2026)
 Figure 21. Interventional Oncology Microspheres Consumed in Hepatocellular Carcinoma
 Figure 22. Global Interventional Oncology Microspheres Market: Hepatocellular Carcinoma (2021-2026) & (K Units)
 Figure 23. Interventional Oncology Microspheres Consumed in Colorectal Cancer Liver Metastases
 Figure 24. Global Interventional Oncology Microspheres Market: Colorectal Cancer Liver Metastases (2021-2026) & (K Units)
 Figure 25. Interventional Oncology Microspheres Consumed in Neuroendocrine Tumor Liver Metastases
 Figure 26. Global Interventional Oncology Microspheres Market: Neuroendocrine Tumor Liver Metastases (2021-2026) & (K Units)
 Figure 27. Interventional Oncology Microspheres Consumed in Intrahepatic Cholangiocarcinoma
 Figure 28. Global Interventional Oncology Microspheres Market: Intrahepatic Cholangiocarcinoma (2021-2026) & (K Units)
 Figure 29. Interventional Oncology Microspheres Consumed in Others
 Figure 30. Global Interventional Oncology Microspheres Market: Others (2021-2026) & (K Units)
 Figure 31. Global Interventional Oncology Microspheres Sale Market Share by Application (2025)
 Figure 32. Global Interventional Oncology Microspheres Revenue Market Share by Application in 2025
 Figure 33. Interventional Oncology Microspheres Sales by Company in 2025 (K Units)
 Figure 34. Global Interventional Oncology Microspheres Sales Market Share by Company in 2025
 Figure 35. Interventional Oncology Microspheres Revenue by Company in 2025 ($ millions)
 Figure 36. Global Interventional Oncology Microspheres Revenue Market Share by Company in 2025
 Figure 37. Global Interventional Oncology Microspheres Sales Market Share by Geographic Region (2021-2026)
 Figure 38. Global Interventional Oncology Microspheres Revenue Market Share by Geographic Region in 2025
 Figure 39. Americas Interventional Oncology Microspheres Sales 2021-2026 (K Units)
 Figure 40. Americas Interventional Oncology Microspheres Revenue 2021-2026 ($ millions)
 Figure 41. APAC Interventional Oncology Microspheres Sales 2021-2026 (K Units)
 Figure 42. APAC Interventional Oncology Microspheres Revenue 2021-2026 ($ millions)
 Figure 43. Europe Interventional Oncology Microspheres Sales 2021-2026 (K Units)
 Figure 44. Europe Interventional Oncology Microspheres Revenue 2021-2026 ($ millions)
 Figure 45. Middle East & Africa Interventional Oncology Microspheres Sales 2021-2026 (K Units)
 Figure 46. Middle East & Africa Interventional Oncology Microspheres Revenue 2021-2026 ($ millions)
 Figure 47. Americas Interventional Oncology Microspheres Sales Market Share by Country in 2025
 Figure 48. Americas Interventional Oncology Microspheres Revenue Market Share by Country (2021-2026)
 Figure 49. Americas Interventional Oncology Microspheres Sales Market Share by Function (2021-2026)
 Figure 50. Americas Interventional Oncology Microspheres Sales Market Share by Application (2021-2026)
 Figure 51. United States Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 52. Canada Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 53. Mexico Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 54. Brazil Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 55. APAC Interventional Oncology Microspheres Sales Market Share by Region in 2025
 Figure 56. APAC Interventional Oncology Microspheres Revenue Market Share by Region (2021-2026)
 Figure 57. APAC Interventional Oncology Microspheres Sales Market Share by Function (2021-2026)
 Figure 58. APAC Interventional Oncology Microspheres Sales Market Share by Application (2021-2026)
 Figure 59. China Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 60. Japan Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 61. South Korea Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 62. Southeast Asia Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 63. India Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 64. Australia Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 65. China Taiwan Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 66. Europe Interventional Oncology Microspheres Sales Market Share by Country in 2025
 Figure 67. Europe Interventional Oncology Microspheres Revenue Market Share by Country (2021-2026)
 Figure 68. Europe Interventional Oncology Microspheres Sales Market Share by Function (2021-2026)
 Figure 69. Europe Interventional Oncology Microspheres Sales Market Share by Application (2021-2026)
 Figure 70. Germany Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 71. France Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 72. UK Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 73. Italy Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 74. Russia Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 75. Middle East & Africa Interventional Oncology Microspheres Sales Market Share by Country (2021-2026)
 Figure 76. Middle East & Africa Interventional Oncology Microspheres Sales Market Share by Function (2021-2026)
 Figure 77. Middle East & Africa Interventional Oncology Microspheres Sales Market Share by Application (2021-2026)
 Figure 78. Egypt Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 79. South Africa Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 80. Israel Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 81. Turkey Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 82. GCC Countries Interventional Oncology Microspheres Revenue Growth 2021-2026 ($ millions)
 Figure 83. Manufacturing Cost Structure Analysis of Interventional Oncology Microspheres in 2026
 Figure 84. Manufacturing Process Analysis of Interventional Oncology Microspheres
 Figure 85. Industry Chain Structure of Interventional Oncology Microspheres
 Figure 86. Channels of Distribution
 Figure 87. Global Interventional Oncology Microspheres Sales Market Forecast by Region (2027-2032)
 Figure 88. Global Interventional Oncology Microspheres Revenue Market Share Forecast by Region (2027-2032)
 Figure 89. Global Interventional Oncology Microspheres Sales Market Share Forecast by Function (2027-2032)
 Figure 90. Global Interventional Oncology Microspheres Revenue Market Share Forecast by Function (2027-2032)
 Figure 91. Global Interventional Oncology Microspheres Sales Market Share Forecast by Application (2027-2032)
 Figure 92. Global Interventional Oncology Microspheres Revenue Market Share Forecast by Application (2027-2032)

Companies Mentioned

Boston Scientific Corporation

Merit Medical Systems, Inc.

Terumo Corporation

Sirtex Medical Pty Ltd.

Varian Medical Systems, Inc.

ABK Biomedical Inc.

IMBiotechnologies Ltd.

Magle Group AB

Serumwerk Bernburg AG

Teleflex Incorporated

Suzhou Mednova Yi Medical Technology Co., Ltd.

Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.

Shanghai H&H Healthcare Technology Company Ltd.

Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd.

Shanghai Weimu Medical Technology Co., Ltd.

Shanghai Yisimiao Medical Devices Co., Ltd.

Hainan Baimaike Medical Technology Co., Ltd.

Hunan APT Medical Inc.

Shanghai Tuomai Medical Technology Co., Ltd.

Huanxin Medical Technology (Suzhou) Co., Ltd.

Digray Medical Technology (Suzhou) Co., Ltd.

Shanghai Fangrun Interventional Medical Devices Co., Ltd.

Hangzhou Yangshun Medical Technology Co., Ltd.

Suzhou Haowei Biomedical Technology Co., Ltd.

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff